During the past decade,
use of organophosphate compounds as flame
retardants and plasticizers has increased. Numerous studies investigating
biomarkers (i.e., urinary metabolites) demonstrate ubiquitous human
exposure and suggest that human exposure may be increasing. To formally
assess temporal trends, we combined data from 14 U.S. epidemiologic
studies for which our laboratory group previously assessed exposure
to two commonly used organophosphate compounds, tris(1,3-dichloro-2-propyl)
phosphate (TDCIPP) and triphenyl phosphate (TPHP). Using individual-level
data and samples collected between 2002 and 2015, we assessed temporal
and seasonal trends in urinary bis(1,3-dichloro-2-propyl) phosphate
(BDCIPP) and diphenyl phosphate (DPHP), the metabolites of TDCIPP
and TPHP, respectively. Data suggest that BDCIPP concentrations have
increased dramatically since 2002. Samples collected in 2014 and 2015
had BDCIPP concentrations that were more than 15 times higher than
those collected in 2002 and 2003 (10β = 16.5; 95%
confidence interval from 9.64 to 28.3). Our results also demonstrate
significant increases in DPHP levels; however, increases were much
smaller than for BDCIPP. Additionally, results suggest that exposure
varies seasonally, with significantly higher levels of exposure in
summer for both TDCIPP and TPHP. Given these increases, more research
is needed to determine whether the levels of exposure experienced
by the general population are related to adverse health outcomes.